alacepril (Q3290792)

alacepril (English)

14 October 2016

C₂₀H₂₆N₂O₅S

1 reference

alacepril (English)

14 October 2016

CC(CSC(=O)C)C(=O)N1CCCC1C(=O)NC(CC2=CC=CC=C2)C(=O)O

1 reference

alacepril (English)

14 October 2016

C[C@H](CSC(=O)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O

1 reference

InChI=1S/C20H26N2O5S/c1-13(12-28-14(2)23)19(25)22-10-6-9-17(22)18(24)21-16(20(26)27)11-15-7-4-3-5-8-15/h3-5,7-8,13,16-17H,6,9-12H2,1-2H3,(H,21,24)(H,26,27)/t13-,16+,17+/m1/s1

alacepril (English)

14 October 2016

antihypertensive drug

1 reference

stated in

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

Alacepril

0 references

Identifiers

InChI

1 reference

alacepril (English)

14 October 2016

2 references

Global Substance Registration System

alacepril (English)

14 October 2016

ChEBI release 2020-09-01

CAS Registry Number

74258-86-9

2 references

stated in

UNII

X39TL7JDPF

alacepril (English)

14 October 2016

https://commonchemistry.cas.org/detail?cas_rn=74258-86-9

9 April 2021

1 reference

Alacepril (English)

14 October 2016

2 references

English

title

alacepril (English)

retrieved

14 October 2016

ChEBI ID

31182

mapping relation type

exact match

2 references

stated in

ChEBI release 2019-10-02

International Chemical Identifier

InChI

InChI=1S/C20H26N2O5S/c1-13(12-28-14(2)23)19(25)22-10-6-9-17(22)18(24)21-16(20(26)27)11-15-7-4-3-5-8-15/h3-5,7-8,13,16-17H,6,9-12H2,1-2H3,(H,21,24)(H,26,27)/t13-,16+,17+/m1/s1

1 reference

ALACEPRIL (English)

14 October 2016

2 references

inferred from InChIKey

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

1 reference

2 references

DSSTOX compound identifier

0 references

0 references

1 reference

Medical Subject Headings

14 March 2018

2 references

Global Substance Registration System

UNII

X39TL7JDPF

English

title

alacepril (English)

retrieved

14 October 2016